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Abstract
Background: Tissue characterisation with cardiovascular magnetic resonance
(CMR) parametric mapping has the potential to detect and quantify both focal
and diffuse alterations in myocardial structure not assessable by late gadolinium
enhancement. Native T1 mapping in particular has shown promise as a useful
biomarker to support diagnostic, therapeutic and prognostic decision-making in
ischaemic and non-ischaemic cardiomyopathies.
Methods: Convolutional neural networks (CNNs) with Bayesian inference are a
category of artificial neural networks which model the uncertainty of the network
output. This study presents an automated framework for tissue characterisation
from native ShMOLLI T1 mapping at 1.5 Tesla using a Probabilistic Hierarchical
Segmentation (PHiSeg) network [1]. In addition, we use the uncertainty
information provided by the PHiSeg network in a novel automated quality control
(QC) step to identify uncertain T1 values. The PHiSeg network and QC were
validated against manual analysis on a cohort of the UK Biobank containing
healthy subjects and chronic cardiomyopathy patients (N=100 for the PHiSeg
network and N=700 for the QC). We used the proposed method to obtain
reference T1 ranges for the left ventricular myocardium in healthy subjects as well
as common clinical cardiac conditions.
Results: T1 values computed from automatic and manual segmentations were
highly correlated (r=0.97). Bland-Altman analysis showed good agreement
between the automated and manual measurements. The average Dice metric was
0.84 for the left ventricular myocardium. The sensitivity of detection of erroneous
outputs was 91%. Finally, T1 values were automatically derived from 14,683
CMR exams from the UK Biobank.
Conclusions: The proposed pipeline allows for automatic analysis of myocardial
native T1 mapping and includes a QC process to detect potentially erroneous
results. T1 reference values were presented for healthy subjects and common
clinical cardiac conditions from the largest cohort to date using T1-mapping
images.
Keywords: Native T1 Mapping; Convolutional Neural Networks; Automatic
Analysis; Cardiac MR Segmentation; Quality Control; UK Biobank
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Background/Introduction
Cardiovascular magnetic resonance (CMR) provides insights into myocardial struc-
ture and function noninvasively, with high diagnostic accuracy and without ionising
radiation. Late Gadolinium Enhancement (LGE) has become the reference standard
for non-invasive imaging of myocardial scar and focal fibrosis in both ischaemic [2]
and non-ischaemic cardiomyopathy [3]. LGE is useful in cardiac conditions which
have stark regional differences within the myocardium, but it cannot correctly vi-
sualise myocardial pathology that is diffuse in nature and affects the myocardium
uniformly. Examples include diffuse myocardial inflammation, fibrosis, hypertrophy,
and infiltration [4]. In contrast, native T1-mapping provides quantitative myocar-
dial tissue characterisation, without the need for gadolinium [5]. Previous work
has shown that T1 mapping can help to detect diffuse myocardial disease in early
disease stages and aids in diagnosing the diseases’ underlying cardiac dysfunction.
Despite its recognised potential, T1 mapping analysis typically requires time-
consuming manual segmentation of T1 maps. Moreover, external factors, such as
hematocrit and blood flow, impact the obtained values and create variability that
reduces the ability to separate healthy from diseased myocardium. Several blood
correction models have been proposed to limit the impact of external factors [6, 7, 8].
However, these methods have not been evaluated in large cohort studies. Automat-
ing T1 analysis of myocardial tissue characterisation sequences could facilitate the
clinical use of T1 mapping and unlock the potential to obtain T1 data in large
populations.
In recent years, deep learning methods have shown great success in segmenting
anatomical and pathological structures in medical images [9, 10, 11]. For many tasks,
their accuracy is comparable to human-level performance, or even surpasses it. In
the context of CMR imaging, semi-automatic and automatic techniques for cardiac
cine [10, 9] and flow [12] imaging have been developed. One paper has proposed
an automated segmentation method for native T1 maps [11]. However, this method
only extracted global left ventricle (LV) myocardial T1 values, whereas regional
assessment of septal and/or focal lesion T1 values is typically used to characterise
diseases [13, 14]. Furthermore, T1 values were only reported for healthy subjects
and a pooled group of cardiovascular diseases (CVD), without distinguishing be-
tween different myocardial disease processes and these values were not corrected for
myocardial blood volume. In this paper we add further insight into the aforemen-
tioned areas.
Medical segmentation problems are often characterised by ambiguities, some of
them inherent to the data such as poor contrast, inhomogeneous appearance and
variations in imaging protocol, and some due to inter- and intra-observer variabil-
ity in the annotated data used for training. To limit the effect of these factors
and detect failed cases, some groups have proposed to incorporate quality control
(QC) techniques [11, 10, 15]. We believe that modeling uncertainty at a per-pixel
level is an important step in understanding the reliability of the segmentations and
increasing clinicians’ trust in the model’s outputs. Several works have investigated
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uncertainty estimation for deep neural networks [16, 17, 18]. A popular approach
to account for the uncertainty in the learned model parameters is to use variational
Bayesian methods, which are a family of techniques for approximating Bayesian
inference over the network weights. These methods can be used to automatically
segment the anatomy of interest, but additionally provide a pixel-wise uncertainty
map of the confidence of the model in segmenting the input image. Budd et al [19]
proposed to use this approach to automatically estimate fetal Head Circumference
from Ultrasound imaging and provide real-time feedback on measurement robust-
ness.
In this paper, we develop a tool for automated segmentation and analysis of T1
maps. We use the PHiSeg network [1] to segment the images, and additionally use
the generated uncertainty information in a novel QC process to identify uncertain
(and potentially inaccurate) segmentations. To the best of our knowledge this is
the first time that segmentation uncertainty information has been used for QC
in medical image segmentation. By incorporating this QC process, our framework
automatically controls the quality of the segmentations and rejects those that are
uncertain. We hypothesise that this method can be used to derive high quality
T1 data without human interaction from large-scale databases. Using the proposed
method we compute mean global and regional native T1 values from 14,683 subjects
from the UK Biobank, which represents the largest cohort for T1 mapping images
to date. We report reference values for healthy subjects and interrogate typical
values obtained in important relevant subgroups of cardiomyopathies. In addition,
we investigate if a blood correction model for T1 [6] provides better discrimination
between healthy and diseased myocardium.
Materials and Methods
UK Biobank dataset
CMR imaging was carried out on a 1.5 Tesla scanner (Siemens Healthcare, Er-
langen, Germany). For each subject, the Shortened Modified Look-Locker Inver-
sion recovery technique (ShMOLLI, WIP780B) was used to perform native (non-
contrast) myocardial T1 mapping in a single mid-ventricular short axis (SAX) slice
(TE/TR/flip-angle (FA): 1.04ms/ 2.6ms/ 35◦, voxel size 0.9 x 0.9 x 8.0 mm). The
matrix size of all images was unified to 192 x 192. Details of the full image acquisi-
tion protocol can be found in [20].
As pre-processing, all of the CMR DICOM images were converted into NIfTI
format. Training and validation data were obtained through manual segmentation
of the images by an experienced CMR cardiologist. The LV endocardial and epicar-
dial borders and the right ventricle (RV) endocardial border were traced using the
ITK-SNAP interactive image visualisation and segmentation tool [21].
From the UK Biobank database, we first excluded any subject with systemic
disease. Subsequently, we identified patients with CVD from the included cohort
using ICD10 codes. We included 11 relevant groups of CVD: acute myocarditis,
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aortic stenosis (AS), atrial fibrillation (AF), cardiac sarcoidosis, chronic coronary
artery disease (CAD), dilated cardiomyopathy (DCM), hypertrophic cardiomyopa-
thy (HCM), pheochromocytoma, obsesity or takotsubo cardiomyopathy. Of the
remaining subjects, those who had no history of CVD nor any cardiovascular risk
factors were included as healthy subjects.
From the selected study population, we randomly chose three sub-cohorts: a set
of 800 subjects (consisting of both healthy subjects as well as subjects with a wide
variety of CVDs) for training, a set of 100 subjects (50 healthy subjects and 50
chronic cardiomyopathy subjects) for validation of the segmentations provided by
the PHiSeg network, and a set of 700 subjects (500 healthy subjects and 200 chronic
cardiomyopathy subjects) for the validation of the QC process.
Automated image analysis
The proposed workflow for automated T1 map analysis is summarised in Figure 1
and described in detail in the following subsections.
Deep neural network with Bayesian inference for segmentation
In this work, we used a Probabilistic Hierarchical Segmentation (PHiSeg) network
[1], a recently proposed deep learning network with Bayesian inference for segmen-
tation of the LV blood pool, LV myocardium and RV blood pool from T1 mapping
images (Figure 1). The PHiSeg network employs convolutions to learn task-specific
representations of the input data and predicts a pixel-wise segmentation from an
input image based on this representation. In addition, an uncertainty map is gen-
erated which quantifies the pixel-wise uncertainty of the segmentation.
The PHiSeg network [1] models the segmentation problem at multiple scales from
fine to coarse. Performing inference with this model using a conditional variational
autoencoder approach results in a network architecture resembling the commonly
used U-Net. However, in contrast to a U-Net, this network allows modelling of
the joint probability of all pixels in the segmentation map. Specifically, it allows
sampling multiple plausible segmentation hypotheses for an input image. In this
manner, in addition to producing a per pixel prediction of the label class, it also
allows estimation of the uncertainty corresponding to each pixel. The network ar-
chitecture features a number of convolutional layers, each using a 3x3 kernel and a
rectified linear unit (ReLU) activation function. After every three convolutions, the
feature map is downsampled by a factor of 2 to learn more global scale features.
After performing probabilistic inference at each level, the learned features are up-
sampled and fused to produce a predicted segmentation mask and a uncertainty
map at the original image resolution. To train the model, we aim to find the neu-
ral network parameters which maximise the evidence lower bound (ELBO), which
models the marginal likelihood of the observed data. The general idea is that a
higher marginal likelihood for a given model indicates a better fit of the data by
that model and hence a greater probability that the model in question was the one
that generated the data [22]. A detailed description of the method, as well as the
network architecture can be found in [1].
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Network training and testing
For training of the network, all images were cropped using the manual segmentation
to the same size of 192×192 and intensity normalised to the range of [0,1]. Data
augmentation was performed on-the-fly using random translations, rotations, scal-
ings and intensity transformations to each mini-batch of images before feeding them
to the network. Each mini-batch consisted of 20 native T1 images. To optimise the
loss function we used the Adam optimiser, with the momentum set to 0.9 and the
learning rate to 10−3. The models were trained for 50,000 iterations on a NVIDIA
GeForce GTX TITAN GPU and the model with highest average Dice score (on the
validation set) over all classes was selected.
Generating uncertainty maps
During test time, we used the PHiSeg network to sample T different segmentation
output samples for a single given input (we used T=100). From these multiple seg-
mentations the final predicted segmentation was calculated as the average softmax
probability over all of the segmentation samples, and the uncertainty map was gen-
erated by computing the cross entropy between the mean segmentation mask and
the segmentation samples.
Quality control
Our QC process comprises two steps, both based upon different aspects of the un-
certainty information provided by the PHiSeg network. To train these QC steps, we
manually labelled the PHiSeg-obtained segmentations as correct or incorrect in a
cohort of 800 subjects (consisting of both healthy subjects as well as subjects with
a wide variety of CVDs).
First, we used the ELBO output [1, 22] of the trained PHiSeg network to reject
uncertain segmentations. The ELBO quantifies how likely it is that the segmenta-
tion is correct. We used the manual labellings to determine a threshold and any
ELBO value above this threshold resulted in the segmentation being rejected.
The second QC step is defined as an image classification problem, where each
image/segmentation pair is classified as accurate or inaccurate. The outputs of the
PHiSeg network (i.e. the segmentation and uncertainty map) were used as input to
a deep learning image classifier. For the image classifier, we used a VGG-16 CNN
network [23], which consists of a stack of convolutional layers followed by three
fully-connected layers for classification. Each convolutional layer uses a 3x3 kernel
and is followed by batch normalisation and ReLU. Details of the VGG-16 network
can be found in [23].
Data are rejected if either of these two QC steps fails. The combination of these
two steps ensures that T1 images acquired on different planes or with inaccurate
segmentations are identified and rejected for further analysis.
T1 map analysis
Myocardial T1 values were measured from the mid-ventricular SAX slice for the
whole myocardium, as well as for the interventricular septum and free-wall seg-
ments separately. From the predicted segmentation, the RV-LV intersection points
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were automatically detected from the LV/RV segmentation masks (RV1 and RV2
in Figure 1) using the hit-or-miss transform, which is a morphological operation
that detects a given configuration (or pattern) in an image. In our case, we aimed
to detect the intersection between background, LV myocardium and RV labels.
These RV-LV intersections were used to divide the LV myocardium mask into a LV
interventricular septum (LVIVS) mask and a LV free-wall (LVFW) mask.
Myocardial T1 blood correlation
For myocardial T1 blood correlation, we used the model proposed by Nickander et al
[6], which used a linear correlation between myocardial T1 and blood measurements
as follows:
T1
corrected = T1
uncorrected + α · (Rmean − Rpatient), (1)
where T1
uncorrected is the native myocardial T1 value, Rmean is the mean R1 for
the patient cohort, and α is calculated as the slope of the linear regression between
myocardial T1 and blood T1 measurements.
The blood T1 value was computed from RV and LV blood pool regions of interest
(ROI) in the mid-ventricular SAX T1 map. To generate the LV and RV ROIs we
eroded the LV/RV blood pool segmentations to generate a mask that has 1/3 of
the area of the original mask (see Figure 2). To ensure that no papillary muscles or
trabeculae were included, we rejected any pixel whose T1 value was less than 1.5
times the interquartile range below the first quartile of the blood pool values. The
blood T1 value was calculated as the mean of the LV and RV values calculated in
this way, and then converted to the T1 relaxation rate (R1=1/T1).
Reference values
In total, we analysed CMR scans of 14,683 subjects (62 ± 22 yrs., 48% males)
included in the UK Biobank cohort using our method. First, we derived reference
values in 5,685 healthy subjects, selected using stringent criteria to exclude any dis-
ease or risk factor that impacts the heart or vasculature (see details in our previous
paper [10]). Next, we analysed data of patients known to have one of 11 different
CVD’s. We also obtained indexed LV end diastolic volume (iLVEDV), LV ejection
fraction (LVEF) and indexed LV mass (iLVM) from cine CMR data, using the
automated method described in [10]. Outliers were defined a priori as values 3 in-
terquartile ranges below the first or above the third quartile and they were removed
from the analysis.
Evaluation of the method
We evaluated the performance of the automated network as follows:
Deep neural network with Bayesian inference: To validate the PHiSeg
network, a cohort of 50 healthy volunteers and 50 chronic cardiomyopathy patients
was selected and manually segmented. These subjects were not used for training the
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PHiSeg network. We used the Dice metric to measure the degree of overlap between
the automated and manual segmentations. The Dice metric has values between 0
and 1, where 0 denotes no overlap and 1 denotes perfect agreement. Furthermore,
Bland-Altman analysis and Pearsons correlation were used to compare the obtained
global LV native myocardial T1 values, and the T1 values in the LVIVS and LVFW,
between the automated and manual segmentations.
Quality control: To assess the accuracy of the QC process, we manually labelled
the PHiSeg obtained segmentations as correct or incorrect in a cohort of 500 healthy
volunteers and 200 chronic cardiomyopathy patients, which are independent from
the training cohort. We computed sensitivity (% of manually labelled as incorrect
image/segmentation pairs that were correctly detected), specificity (% of manually
labelled as correct image/segmentation pairs that were correctly identified), and
balanced accuracy (averaged percentages of correct answers for correct/incorrect
classes individually).
Statistical analysis
Statistical analysis was performed using Statsmodels, a Python library for statis-
tical and econometric analysis [24]. Normality of distributions was tested with the
Kolmogorov-Smirnov test. Categorical data are expressed as percentages, and con-
tinuous variables as mean ± standard deviation (SD) or median and interquartile
range, as appropriate. A paired 2-tailed Student’s t-test was used to assess paired
data, and an unpaired 2-tailed Student’s t-test was used to assess unpaired sam-
ples. Comparison of more than three normally distributed variables was performed
using analysis of variance (ANOVA, with Bonferronis post-hoc correction). For the
Bland-Altman analysis, paired t-tests versus zero values were used to verify the
significance of the biases, and paired t-tests were used to analyse the mean absolute
errors of all parameters between healthy subjects and patients. Linear regression
was performed to estimate the slope used for correction of myocardial T1 from
blood T1. The relationships between corrected and uncorrected mean native my-
ocardial T1 were investigated by computing the SD of the mean native myocardial
T1, and evaluated for difference with a F-test. To investigate whether blood cor-
rection improved the discrimination between healthy subjects and patients with
CVD’s, we calculated the z-scores of the patients in each CVD group with respect
to our healthy population for the uncorrected and corrected T1 maps and compared
the average z-scores using a paired 2-tailed Student’s t-test. Associations between
native T1 values, clinical demographics and LV function were explored by single and
multivariate linear regressions. In all cases, p < 0.05 denotes statistical significance.
To compute reference values, healthy subjects were used as the study controls and
unpaired t-tests were used for comparison.
Results
Deep neural network with Bayesian inference
Table 1 reports the Dice scores between automated and manual segmentations eval-
uated on the cohort of 100 subjects. Overall, the Dice score between manual and
automated segmentations was 0.84 for the LV myocardium.
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The Bland-Altman plot showed strong agreement between the pipeline and man-
ual analysis, see Figure 3. There was a small negative bias for all of the native T1
values (-5.04 ms, 5.89 ms and -4.97 for global LV, LVIVS and LVFW respectively).
Table 2 shows the automatically and manually calculated T1 values within the three
regions averaged over the test cohort. There was no significant difference in mean
absolute error between chronic cardiomyopathy patients and healthy volunteers for
any of the T1 values extracted except for LVIVS T1 values for chronic cardiomyopa-
thy patients. The automatically reconstructed T1 maps showed a strong correlation
with the T1 values based on manual segmentations (r=0.97) (see Supplementary
Figure 3).
Figure 4 shows an example of a manual segmentation, the predicted segmentation
and the uncertainty map for a healthy subject and for a chronic cardiomyopathy
patient. Note that the manual and the automatic segmentations agree well.
Quality control
The balanced accuracy for the QC process was 97.08%, the sensitivity was 90.08%
and the specificity was 96.44%.
Figure 5 shows examples of uncertainty maps for a cohort of subjects that have
been rejected by the QC steps. Note that the QC is able to identify inaccurate data
with a wide range of underlying causes such as incorrect planning (i.e. images (a),
(b), (c) and (d) in Figure 5), motion artefacts (i.e. images (e) and (f) in Figure 5)
or segmentation failure (images (g) and (h) in Figure 5).
Uncertainty quantification
To understand the impact of uncertainty in the predicted T1 values, from the test
cohort that contains 50 healthy volunteers and 50 chronic cardiomyopathy patients,
we computed the distribution of the global LV T1 values over the T predicted
segmentations. Figure 7 shows a graphical representations of the variability of these
estimates. The solid lines indicate the mean T1 values from the test cohort and the
shaded region represents one SD of uncertainty.
Myocardial T1 blood correlation
The constants from the linear regression model between the myocardial T1 and the
blood measurements were used to correct native myocardial T1 values according to
Equation 1. The global R2 was 0.28 (which is comparable to that found in [6]) and
the mean squared error was 106.4. The linear regression had a slope of -0.35 and
an intercept of 935.
The mean uncorrected myocardial T1 in the healthy cohort was 946.44 ± 61.64,
and the mean corrected myocardial T1 in the healthy cohort was 927.62 ± 46.41,
showing a statistically significant decrease of the SD ((p < 0.001)).
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Reference values
From the 14,683 subjects, 156 subjects were rejected by our QC process due to
inaccurate T1 segmentations. Subject characteristics are summarised in Table 3.
Compared to healthy subjects, all patients were in the same age range; patients
with obesity had statistically higher body mass index (BMI) and body surface area
(BSA); patients with DCM, AF and chronic CAD had significantly lower LVEF
(all p < 0.05); patients with HCM, AS and chronic CAD had significantly higher
iLVM (all p < 0.05). Native T1 in three different regions (LV, LVIVS, LVFW) in
CVD subjects and in healthy subjects are shown in Table 5. Gender did not affect
myocardial T1 values significantly (2-way ANOVA, p = 0.01), and thus only overall
T1 values are reported.
Native T1 values in typical tissue classes in CVD subjects and in healthy subjects
for uncorrected and corrected myocardial LVIVS T1 values are shown in Figure 6.
Table 5 shows global and regional native correlated T1 values. Compared to healthy
subjects, patients with DCM, HCM, Takotsubo cardiomyopathy, acute myocarditis
and cardiac sarcoidosis had significantly higher native T1 values.
Finally, Table 4 shows LVIVS native correlated T1 values stratified by age by
decade (45 to 54, 55 to 64, and 65 to 74 years), and reported as mean and reference
ranges (95% prediction intervals). Note that, in the first age range, i.e. 45-55, there
were not enough data to compute the confidence interval for the AS group.
Discussion
In this work, we have proposed a fully automated pipeline with a novel quality
control step to automatically quantify myocardial tissue from native T1 mapping,
which allows extraction of reference values from large-scale databases. The method
is fast and scalable, overcoming limitations associated with current clinical CMR
image analysis workflows, which are manual, time-consuming and prone to subjec-
tive error. The method has potential to automate T1 mapping analyses from CMR
in clinical practice and research. Using the proposed pipeline we present reference
ranges for global and regional myocardial native T1 in healthy subjects from the UK
Biobank dataset and show that blood correction improves discrimination between
healthy subjects and patients with CVD.
Automatic analysis with quality control
We validated our segmentation network by comparing between automated and
manual analysis in a cohort of healthy and diseased subjects. Results show a strong
agreement for both segmentations (see Table 1) as well as estimated T1 values (Fig-
ures 3 and 3). Residual biases in automated T1 calculations might not necessarily
correspond to T1 estimation errors but might be related to the different methods
used to compute T1 between manual and automatic analysis. Residual biases are
within the range of inter- and intraobserver variabilities previously reported [25].
Also, residual biases (ranging between -4.97ms and -5.04ms) are consistent between
healthy and cardiac patients and are unlikely to have significant clinical impact.
The Dice scores we obtained are comparable to previous works [11].
Puyol-Anto´n et al. Page 10 of 18
Quality control techniques are essential to be able to translate deep learning al-
gorithms into a clinical setting. However, many works proposed for the analysis of
CMR data have not taken this need into account making it impossible to deploy
them for the processing of large-scale databases. In our framework, we employed
a novel approach that used the uncertainty information produced by a CNN with
Bayesian inference to identify incorrect segmentations, which can be rejected or
flagged for revision by an expert cardiologist. We show that this QC process yields
over 90% sensitivity of detecting errors, getting close to clinical standards. One way
to further optimize QC in our network would be to incorporate anatomical informa-
tion into the uncertainty estimation. At the moment, segmentation errors of both
RV and LV are accounted for similarly, while the segmentation of the LV is most
important for T1 calculations.
Reference values:
We used our framework to analyse native T1 maps in an unprecedentedly large co-
hort of healthy volunteers and patients with heart disease. Using this cohort we were
able to provide reference values for normal myocardium in aging subjects. T1 values
differ between different scanners, vendors and protocols. Our values can therefore
not directly compare to other publications, but they are in agreement with results
obtained in smaller cohorts of manual assessment [8, 26, 27]. We further used our
cohort to interrogate T1 values in patients with 11 different CVDs. We show that for
CVDs in which diffuse myocardial disease is prominent (acute myocarditis, cardiac
sarcoidosis, HCM, DCM and tako Tsubo disease) we detect significantly larger T1
values. For the other CVD’s, we show that T1 values did not significantly change
from healthy data. It is likely that the extent of myocardial damage in these groups
is less high, explaining the lower T1 values. There is large variability seen in native
T1 values, which is known to be caused by several factors, including intracardiac
blood flow and hematocrite levels. We investigated a previously proposed method
for correction of T1 values based on blood pool T1 dynamics [6]. This method has
the benefit on working using image data alone, but has not previously been tested
in a large cohort of patients. We demonstrate that indeed, discrimination between
health and disease improves using blood pool correction. Whether this technique is
better than using hematocrite-correction or other methods needs is to be investi-
gated in further studies. Investigating myocardial disease processes should include
additional measures to native T1, such as extracellular volume or T2 imaging. How-
ever, the data presented in our study remain valuable. The UK Biobank cohort will
contain highly detailed imaging and non-imaging data and follow-up in nearly half
a million subjects. On this large scale, new relationships between T1 and popula-
tion characteristics can yield important insights into development and progression
of CVDs.
Limitations and future directions:
A limitation of our work is that the PHiSeg network was trained on a single dataset,
the UK Biobank dataset, which is relatively homogeneous. To obtain similar per-
formance in other databases it would be necessary to retrain the networks using a
small amount of data. However, the proposed segmentation model and QC steps
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will remain applicable.
Another limitation of this study is the lack of availability of paired LGE and
native T1-mapping data to assess the correlation between these two measurements,
and in which cases T1-mapping could provide a better insight into cardiac patholo-
gies. Based on previous studies, it is known that T1-mapping may enable detection
of early pathological processes, and serve as a tool for early diagnosis or screening,
or differentiation of cardiomyopathies from normal phenotypes. The provided ref-
erence ranges could help to identity subjects at risk at an early stage.
The T1 values presented in this study were derived using a single T1-mapping
technique. It is important to take into account that even within the same T1-
mapping technique, different versions of sequences can lead to small differences in
T1-estimations. Therefore, it might not be possible to directly translate the T1 val-
ues derived in this study to other T1-mapping techniques. In future work we aim to
extend the automatic pipeline to be able to accurately segment T1-mapping data
from different sequences/vendors, to make the proposed framework generalisable.
Conclusions
We presented and validated a pipeline for automated quantification of myocardial
tissue from native T1-mapping. The proposed method uses the uncertainty of a
deep learning segmentation network in a novel QC process to detect inaccurate
segmentations. We used the proposed framework to obtain reference values from
the largest cohort of subjects to date, which include data from healthy subjects and
from patients with the most common myocardial tissue conditions.
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AS Aortic stenosis
BMI Body mass index
BPM Beats per minute
BSA Body surface area
CAD Coronary artery disease
CMR Cardiac magnetic resonance
CNN Convolutional neural networks
CVAE Conditional variational autoencoder
CVD Cardiovascular disease
DCM Dilated cardiomyopathy
ELBO Evidence lower bound
HCM Hypertrophic cardiomyopathy
iLVEDV Indexed LV end diastolic volume
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LV Left ventricle
LVEF LV ejection fraction
LVIVS Left ventricle interventricular septum
LVFW Left ventricle free-wall
QC Quality control
PHiSeg Probabilistic Hierarchical Segmentation
ReLU Rectified linear unit
ROI Regions of interest
RV Right ventricle
SAX Short axis
SD Standard deviation
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Figures
Figure 1 Overview of the proposed framework for automatic T1 map analysis. A composition of
(1) the PHiSeg network for segmenting native T1 images, (2) a QC for detecting inaccurate
segmentation, and (3) T1 analysis. PHiSeg, Probabilistic Hierarchical Segmentation
Image
Pred Seg
Uncertainty RV1
RV2
LVIVS
LVFW
T1 Maping analysis
PHiSeg QC 
map
Incorrect
Correct
Figure 2 SAX T1 map with ROIs. The figure shows regions of interest (ROI) drawn for native
myocardial T1 values of the LVIVS, LV and RV blood pool T1 values. LVIS, LV interventricular
septum.
2000 ms
0 ms
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Figure 3 Bland-Altman and correlation plots of the automatic versus manual myocardium T1
values. (A, D) global LV native T1 values, (B, E) LVIVS native T1 values, (C, F) LVFW native T1
values. In the Bland-Altman analysis, the grey dotted line represents the mean bias; the red dotted
lines the limits of agreement. The p−values represent the difference in mean bias from zero using
a paired t-test. In the correlation plots, the red dotted line represents linear regression line. r is
the Pearsons correlation coefficient. LVIVS, LV interventricular septum; LVFW, LV free-wall.
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Figure 4 Illustration of the segmentation results for native T1 images. The top row shows an
example of a healthy subject and the bottom row of a cardiac patient. The cardiac chambers are
represented by different colours.
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Figure 5 Segmentation and uncertainty map results for selected subjects who were rejected by
the QC process The left column represents the T1 mapping images, the middle column the
automated segmentation, and the right column the derived uncertainty map. Red arrows indicated
the regions with high uncertainty.
Image           Segm.          Uncertainty                Image           Segm.         Uncertainty
a)
c)
e)
g)
b)
d)
f)
h)
Table 1 Dice score between automated segmentation and manual segmentation for native T1 images.
Dice values are reported as mean (SD).
Mean dice score
LV Blood pool LV Myocardium RV blood pool
Healthy (n=50) 0.96 (1.81) 0.83 (3.01) 0.92 (4.23)
Chronic cardiomyopathy (n=50) 0.95 (1.46) 0.84 (3.32) 0.93 (4.06)
Average 0.95 (1.63) 0.84 (3.16) 0.92 (4.14)
Table 2 Mean T1 values for the test cohort. T1 are reported as mean (SD). Asterisks indicate
significant differences between T1 values estimated between manual and predicted segmentation
using a paired t-test.
Healthy Chronic cardiomyopathy
global LV LVIVS LVFW LV LVIVS LVFW
Manual 939.33 (65.51) 947.39 (51.37) 935.65 (76.59) 911.18 (47.90) 930.10 (39.16) 902.04 (57.81)
Automatic 953.99 (66.33) 959.19 (59.08) 952.09 (74.16) 921.40 (51.29) 935.01 (37.36)* 912.72 (59.21)
Table 3 Baseline characteristics of study subjects included in the analysis for reference values. All
values are n (%) or mean ± SD. Abbreviations: BMI (body mass index), BSA (body surface area), g
(grams), HR (heart rate), kg (kilograms), iLVEDV (indexed LV end-diastolic volume), LVEF (left
ventricular ejection fraction), iLVM (indexed LV mass), m (metre). Disease names are as per
abbreviations list. * denotes values significantly different from healthy subjects (all p < 0.05).
n Age (years) Male (n) BMI (kg/m2) BSA (m2) HR (bpm) iLVEDV(mL/m2) LVEF (%) iLVM (g/m2)
Healthy 5685 60 (28) 3056 (53.76) 25 (4) 1.84 (0.2) 61 (9) 78 (13) 61 (6) 45 (8)
Acute myocarditis 571 68 (6) 152 (27.19) 28 (5) 1.99 (0.2) 69 (14) 80 (18) 57 (13) 48 (12)
AS 51 68 (7) 15 (29.41) 28 (4) 1.97 (0.2) 73 (5) 83 (23) 59 (6) 56 (13)*
AF 559 68 (6) 152 (27.19) 28 (5) 1.99 (0.2) 72 (11) 80 (18) 51 (9)* 51(11)
Cardiac Sarcoidosis 988 66 (7) 383 (38.77) 30 (6) 2.00 (0.21) 72 (10) 77 (18) 59 (8) 47 (11)
Chronic CAD 1872 67 (7) 576 (30.77) 29 (5) 1.98 (0.2) 60 (10) 79 (18) 48 (9)* 55 (11)*
DCM 567 68 (7) 153 (26.98) 28 (5) 1.99 (0.2) 62 (10) 80 (20) 39 (9)* 56(11)
HCM 571 68 (6) 153 (26.80) 28 (5) 1.99 (0.2) 61 (24) 81 (20) 57 (9) 66 (12)*
Hypertension 973 63 (7) 463 (47.58) 27 (4) 1.91 (0.2) 63 (9) 77 (13) 60 (6) 48 (9)
Pheochromocytoma 948 66 (7) 364 (38.40) 30 (6) 2.01 (0.21) 62 (10) 78 (18) 58 (9) 46 (15)
Obesity 910 66 (7) 343 (37.69) 30 (6)* 2.12 (0.21)* 62 (10) 78 (19) 59 (8) 45 (11)
Takotsubo cardiomyopathy 988 66 (7) 383 (38.77) 30 (6) 2.01 (0.19) 58 (10) 77 (18) 59 (8) 44 (13)
Additional Files
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Figure 6 Box plot for uncorrected and corrected LVIVS T1 for 11 different cardiovascular
conditions and healthy subjects. Characteristic native LVIVS a) uncorrected and b) corrected T1
values (1.5 Tesla) for 12 different cardiovascular conditions. Data presented as box and whisker
plots with the median, upper and lower quartiles, min and max excluding outliers, and outliers
that are more than 3/2 the upper and lower quartiles. Disease names are as per abbreviations list.
* denotes values significantly different from healthy subjects and † denotes a significantly decrease
of z-score from the uncorrected LVIVS T1 values using a paired t-test (all p < 0.05).
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Figure 7 Uncertainty plot for predicted global global LV T1. Data presented in ascending order
of predicted T1 showing mean T1 value and SD of uncertainty for each subject. Colours represent
the different groups in the test cohort.
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Table 4 Age-specific native correlated LVIVS ShMOLLI-T1 reference ranges. Native T1 reference
ranges detailing mean, lower reference limit and upper reference limit by age group. Reference limits
are derived by the upper and lower bounds of the 95% prediction interval for each parameter at each
age group. Abbreviation: LVIVS (left ventricle interventricular septum). Disease names are as per
abbreviations list.
45-54 55-64 65-74
lower mean upper lower mean upper lower mean upper
Healthy 793 930 1066 793 922 1052 781 915 1049
Acute myocarditis 862 973 1084 876 979 1082 853 979 1104
AS 884 851 957 1063 840 956 1072
AF 821 934 1047 838 941 1045 816 941 1066
Cardiac Sarcoidosis 845 950 1055 857 964 1071 838 960 1082
Chronic CAD 822 935 1047 830 940 1050 814 936 1059
DCM 854 965 1076 868 971 1074 846 971 1096
HCM 854 965 1076 868 971 1074 845 971 1096
Hypertension 797 937 1077 814 935 1055 813 941 1068
Pheochromocytoma 822 926 1030 831 937 1044 813 933 1054
Obesity 795 900 1005 807 914 1020 788 909 1030
Takotsubo cardiomyopathy 869 974 1079 881 988 1095 862 984 1106
Table 5 Reference ranges for the native correlated ShMOLLI-T1 ranges. Reference ranges for the
most common myocardial tissue conditions encountered in clinical practice. Abbreviations: LVIVS (left
ventricle interventricular septum), LVFW (left ventricle free-wall). Disease names are as per
abbreviations list. * denotes values significantly different from healthy subjects (all p < 0.05).
n global LV T1 T1 LVIVS T1 LVFW
Healthy 5685 927.62 (46.41) 922.29 (58.23) 937.34 (40.75)
Acute myocarditis 571 998.39 (50.16)* 972.28 (59.24)* 985.59 (41.23)*
AS 51 954.49 (35.02) 943.42 (40.14) 973.51 (34.08)
AF 559 944.28 (49.71) 935.62 (60.01) 966.34 (40.13)
Cardiac Sarcoidosis 988 972.33 (48.35)* 957.07 (57.40)* 984.18 (40.46)*
Chronic CAD 1872 942.46 (47.18) 933.46 (56.58) 959.25 (38.61)
DCM 567 974.72 (47.18)* 968.71 (59.11)* 990.38 (39.16)*
HCM 571 989.41 (50.16)* 968.68 (55.55)* 989.61 (41.29)*
Hypertension 973 943.75 (49.21) 935.68 (58.24) 958.82 (36.75)
Pheochromocytoma 948 944.23 (48.47) 935.94 (56.68) 963.02 (41.60)
Obesity 910 916.35 (47.73) 907.78 (56.94) 932.45 (41.71)
Takotsubo cardiomyopathy 988 991.82 (48.61)* 983.10 (57.45)* 1009.81 (41.68)*
